Stacy M. Moore, Ph.D. - Publications

Affiliations: 
2000 Johns Hopkins University, Baltimore, MD 
Area:
Pharmacology, Molecular Biology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2001 Moore SM, Cannon JS, Tanhehco YC, Hamzeh FM, Ambinder RF. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues. Antimicrobial Agents and Chemotherapy. 45: 2082-91. PMID 11408227 DOI: 10.1128/Aac.45.7.2082-2091.2001  0.513
1999 Cannon JS, Hamzeh F, Moore S, Nicholas J, Ambinder RF. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Journal of Virology. 73: 4786-93. PMID 10233939 DOI: 10.1128/Jvi.73.6.4786-4793.1999  0.594
1999 Ambinder RF, Lemas MV, Moore S, Yang J, Fabian D, Krone C. Epstein-Barr virus and lymphoma. Cancer Treatment and Research. 99: 27-45. DOI: 10.1007/978-0-585-38571-6_2  0.41
1998 Walker TR, Moore SM, Lawson MF, Panettieri RA, Chilvers ER. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: Role in mediating airway smooth muscle proliferation Molecular Pharmacology. 54: 1007-1015. PMID 9855629 DOI: 10.1124/mol.54.6.1007  0.34
1997 Moore SM, Ambinder RF. Pharmacologic induction of Epstein-Barr Virus lytic cycle Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A41. DOI: 10.1097/00042560-199704010-00142  0.474
1996 Ambinder RF, Robertson KD, Moore SM, Yang J. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma. Seminars in Cancer Biology. 7: 217-26. PMID 8946606 DOI: 10.1006/Scbi.1996.0029  0.6
Show low-probability matches.